702798009: linagliptine (substance)

SNOMED CT Concept\substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\inhibiteur d'hydrolase\inhibiteur de l'hydrolase peptidique\Dipeptidyl peptidase IV inhibitor\Linagliptin (substance)

\Drug or medicament (substance)\Linagliptin (substance)

\substance catégorisée selon sa structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Piperidine\Linagliptin (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Quinazoline (substance)\Linagliptin (substance)
\Organic compound\Organic cyclic compound\Heterocyclic compound\Pyridine and/or pyridine derivative\Piperidine\Linagliptin (substance)
\Organic compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Piperidine\Linagliptin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3006132016 Linagliptin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3006177019 Linagliptin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

733181000241111 linagliptine (substance) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)

820861000172112 linagliptine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Linagliptin (substance)	est un(e) (attribut)	Drug or medicament (substance)	true	Inferred relationship	Some
Linagliptin (substance)	est un(e) (attribut)	Oral hypoglycemic (substance)	false	Inferred relationship	Some
Linagliptin (substance)	est un(e) (attribut)	Dipeptidyl peptidase IV inhibitor	true	Inferred relationship	Some
Linagliptin (substance)	Has disposition (attribute)	Dipeptidyl peptidase IV inhibitor (disposition)	true	Inferred relationship	Some
Linagliptin (substance)	est un(e) (attribut)	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Linagliptin (substance)	est un(e) (attribut)	Enzyme inhibitor	false	Inferred relationship	Some
Linagliptin (substance)	est un(e) (attribut)	Piperidine	true	Inferred relationship	Some
Linagliptin (substance)	est un(e) (attribut)	Quinazoline (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Empagliflozin and linagliptin only product	a pour principe actif (attribut)	True	Linagliptin (substance)	Inferred relationship	Some	1
Product containing only linagliptin (medicinal product)	a pour principe actif (attribut)	True	Linagliptin (substance)	Inferred relationship	Some	1
Linagliptin and metformin only product	a pour principe actif (attribut)	True	Linagliptin (substance)	Inferred relationship	Some	2
Product containing only linagliptin and metformin in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Linagliptin (substance)	Inferred relationship	Some	2
Product containing only linagliptin in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Linagliptin (substance)	Inferred relationship	Some	1
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Linagliptin (substance)	Inferred relationship	Some	2
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Linagliptin (substance)	Inferred relationship	Some	2
Product containing linagliptin (medicinal product)	a pour principe actif (attribut)	True	Linagliptin (substance)	Inferred relationship	Some	1
Linagliptin 5 mg oral tablet	a pour principe actif (attribut)	False	Linagliptin (substance)	Inferred relationship	Some
Product containing empagliflozin and linagliptin (medicinal product)	a pour principe actif (attribut)	True	Linagliptin (substance)	Inferred relationship	Some	1
Product containing linagliptin and metformin (medicinal product)	a pour principe actif (attribut)	True	Linagliptin (substance)	Inferred relationship	Some	2
Product containing linagliptin and metformin in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Linagliptin (substance)	Inferred relationship	Some	2
Linagliptin 5 mg oral tablet	a pour principe actif (attribut)	False	Linagliptin (substance)	Inferred relationship	Some	1
Linagliptin 5 mg oral tablet	Has basis of strength substance (attribute)	True	Linagliptin (substance)	Inferred relationship	Some	1
Linagliptin 5 mg oral tablet	Has precise active ingredient	True	Linagliptin (substance)	Inferred relationship	Some	1
Linagliptin-containing product in oral dose form	a pour principe actif (attribut)	True	Linagliptin (substance)	Inferred relationship	Some	1

This concept is not in any reference sets